Page last updated: 2024-10-25

desipramine and Pulmonary Eosinophilia

desipramine has been researched along with Pulmonary Eosinophilia in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mutnick, A1
Schneiweiss, F1

Other Studies

1 other study available for desipramine and Pulmonary Eosinophilia

ArticleYear
Desipramine-induced pulmonary interstitial eosinophilia.
    Drug intelligence & clinical pharmacy, 1982, Volume: 16, Issue:12

    Topics: Adult; Depressive Disorder; Desipramine; Female; Humans; Pulmonary Eosinophilia

1982